Apixaban Formulations

Patent No. EP3257500 (titled "Apixaban Formulations") was filed by Bristol Myers Squibb Ireland on Feb 24, 2011. The application was issued on Oct 16, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3257500

BRISTOL MYERS SQUIBB IRELAND
Application Number
EP17178613A
Filing Date
Feb 24, 2011
Status
Revoked
Mar 22, 2024
Publication Date
Oct 16, 2019